.@MayoClinic#RegenMed has developed a 3D prototype of bioprinted skin to study inflammatory skin diseases such as atopic dermatitis also known as #eczema and test new biotherapeutics.
https://t.co/YReL3Rv5po
.@MayoRegMed is collaborating with a biotech firm to study whether engineered cells could be used as a replacement therapy for people with advanced liver damage from alcoholic hepatitis.
Learn more: https://t.co/Z0jk9v9Q77
.@MayoRegMed is collaborating with a biotech firm to study whether engineered cells could be used as a replacement therapy for people with advanced liver damage from alcoholic hepatitis.
https://t.co/mXLifdSTiq
#Mayo Clinic is the prime site for an @ARPA_H award to develop an implantable device that acts as a living pharmacy to treat inflammatory conditions such as #Crohn's disease and #ulcerative colitis.
https://t.co/FVwvkjheIV
Manufacturing engineers dress in special coveralls and use slow, deliberate movements in a highly controlled environment to bring patients at #MayoClinic first-of-their-kind cell and gene #biotherapies.
https://t.co/bDskpTykGY
Learn about @MayoClinic's groundbreaking work in #laryngeal transplantation. David Lott, M.D., will present "Breaking the silence" at @MayoClinic RegenBio Summit Dec. 9 to 11 in Ponte Vedra Beach, Florida. Register now.
https://t.co/Aiz2XzzBBw
A new ARPA-H award will enable Mayo to lead efforts to develop an implantable device that will revolutionize treatment for inflammatory bowel disease. Read more: https://t.co/Fl8enaBDGB
#Mayo Clinic is the prime site for an @ARPA_H award to develop an implantable device that delivers antibodies to control inflammatory bowel disease and a wearable component that tells the device when to deliver cell therapy.
https://t.co/hr31m2caoY
Regenerative Medicine Minnesota (RMM) has awarded 13 grants totaling $4.3 million to support discovery, development, translation and commercialization of regenerative medicine-based innovations to improve human health in Minnesota and beyond.
Learn more: https://t.co/JUPZ60Rek8
Mayo Clinic is the prime site for an @ARPA_H award to develop an implantable device that delivers antibodies to control inflammatory bowel disease and a wearable component that tells the device when to deliver cell therapy.
Learn more: https://t.co/zk2sRa4F7N
Explore the latest in #RegenMed research to repair damaged cartilage in the hip and knee. Join experts @Sarianl, Jacob Sellon, M.D., and Brennan Boettcher, D.O., for this and more @MayoClinic RegenBio Summit 24 this December in Florida.
https://t.co/jemapnDsGe
Space offers a new frontier for stem cell research. A new @MayoClinic@AbbaZubair review paper explores how stem cells grown in microgravity could have clinical value for cancer, heart disease, and neurodegenerative disorders.
https://t.co/qCD0vr5WZu
#3D bioprinting is a new high-tech tool in #RegenMed research @MayoClinic. Saranya Wyles, M.D., Ph.D. shares 3D #skin bioprinting studies at the Mayo Clinic RegenBio Summit: Transforming Next-Gen Biotherapeutics, Dec. 9 to 11, Ponte Vedra Beach, Florida.
https://t.co/2qfEvjIsNP
.@MayoClinic@ArminGarmany research probes the health of space travelers amid an emerging era of civilian space exploration and private astro business.
https://t.co/iji0mEXF6k
.@MayoClinic research is investigating the health effects of space travel on private citizens. A @MayoProceedings@ArminGarmany paper shares findings of the health response of the first all-civilian astronaut mission to the International Space Station.
https://t.co/xaAWthEDBs
Gene therapy is a new tool that seeks to heal disease at its molecular roots. Hear from an expert who secured approval for the first gene therapy for inherited skin disorders at the #MayoClinic RegenBio Summit this December in Florida.
https://t.co/Ass1PsQiy6